Intuitive Surgical, Inc. Crushed Expectations: So Why the Drop?

Intuitive Surgical easily beat analysts' expectations with its fourth-quarter report. Here's why the stock is dropping now.

Jan 24, 2014 at 2:05PM

Yesterday after the market close, Intuitive Surgical, (NASDAQ:ISRG) reported earnings that absolutely crushed expectations.

Naturally, investors in the robotic-surgery specialist were rewarded with a 6% drop this morning. So, what happened?

Here's what they said
Let's check out the numbers first.

Quarterly revenue decreased 5% year over year to $576 million -- a result driven by a 6% increase in instruments and accessories revenue to $268 million, but offset by the sale of "just" 138 da Vinci Surgical Systems for $205 million, or a 23% drop. But that still easily exceeded analysts' consensus estimates, which called for total sales of $548.56 million.

Meanwhile, thanks largely to Intuitive Surgical's share repurchase efforts, fourth quarter net income per share actually rose slightly to $4.28, compared to estimates for earnings of just $3.76 per share.

Here's what they didn't say
So, why the drop? 

First, keep in mind shares of Intuitive Surgical spiked by as much as 14% after the company preannounced those revenue figures early last week. As of this writing, the stock is still 5.4% higher than it stood the day before that announcement.

Second, and perhaps more importantly, Intuitive Surgical has chosen not to provide forward guidance for now. CEO Gary Guthart explained, "The combination of gynecology trends, the [Affordable Care Act] implementation in the United States, and uncertainty of future capital purchases in Japan creates difficulty in revenue forecast for at least the first half of 2014."

But while Mr. Market understandably hates this kind of uncertainty, I have to applaud Intuitive Surgical's prudence.

After all, there's little sense in taking a shot in the dark given the recent unprecedented changes in the health-care industry. And a bad prediction could not only destroy management's rapport with investors -- something MAKO Surgical shareholders in 2012 remember all too well -- but also add to their already troublesome legal matters with inevitable shareholder lawsuits if said guidance was far enough off base.

Here's the plan for 2014
Intuitive Surgical will obviously continue to support global growth in its core gynecology and urology procedures, but its eyes are also set on grabbing a larger chunk of the fast-growing general-surgery market -- notably with both colorectal and single-incision procedures -- which grew 93% over the last year alone.

In fact, according to Guthart, general surgery overtook urology as the second largest category of da Vinci use in the United States last quarter.

Outside the U.S., Intuitive will look to maintain strong sales momentum in Europe, which played a huge role in 2013 helping international procedures and systems sales grow 21% and 59%, respectively. And though Japan also helped drive those numbers upward last year, management asserted capital sales there will remain unpredictable until 2016, when potentially favorable revisions in Japan's national health care coverage are slated to kick in.

Foolish takeaway
For now, investors are left with a stock that still doesn't look particularly cheap trading around 25 times last year's earnings. But when you back out Intuitive Surgical's enviable $2.8 billion cash pile -- which grew by another $222 million last quarter, by the way -- its trailing P/E ratio falls to 20.

That may not seem extraordinarily cheap, but I think it's a well-deserved premium considering we're still talking about a solidly profitable business that enjoys a massive head start in a cutting-edge industry. In the end, that's why I'm convinced today's pullback represents a fantastic buying opportunity for patient, long-term investors.

Learn everything you need to know about Obamacare in this free report
Confusion surrounding Obamacare has definitely hurt Intuitive Surgical. But while Obamacare may seem complex, it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called Everything You Need to Know About Obamacare. This FREE guide contains the key information and money-making advice that every American must know. Please click here to access your free copy.

Fool contributor Steve Symington has no position in any stocks mentioned. The Motley Fool recommends Intuitive Surgical. The Motley Fool owns shares of Intuitive Surgical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information